Metastatic Endometrial Endometrioid Adenocarcinoma
1 clinical trials · Condition
◉ Watch Metastatic Endometrial Endometrioid Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers (NCT05538897) | National Cancer Institute (NCI) | 2023-03-31 |
Track Metastatic Endometrial Endometrioid Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.